Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade?

Neurology

Volumn 31, Issue 2, 1981, Pages 132-137

  Henderson, Victor W ^a   Wooten, G Frederick ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; DIPHENHYDRAMINE; DOPAMINE RECEPTOR; HALOPERIDOL; LEVODOPA; LITHIUM; NEUROLEPTIC AGENT;

ADVERSE DRUG REACTION; CANCER; CASE REPORT; CENTRAL NERVOUS SYSTEM; DIAGNOSIS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ETIOLOGY; EXTRAPYRAMIDAL SYSTEM; HYPERTHERMIA; MALIGNANT HYPERTHERMIA; MANIA; PARKINSON DISEASE; PATHOGENESIS; SCHIZOPHRENIA; SYNDROME; THERMOREGULATION;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BODY TEMPERATURE REGULATION; CASE REPORT; CREATINE KINASE; FEVER; HALOPERIDOL; HUMAN; HYPOTHALAMUS; LITHIUM; MALE; MIDDLE AGE; RECEPTORS, DOPAMINE; SUPPORT, NON-U.S. GOV'T; SYNDROME;

EID: 0019419216     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.31.2.132     Document Type: Article

References (82)

1. Gerle B: Clinical observations of the side-effects of haloperidol. Acta Psychiatr Scand 40:65-76, 1964
2. Delay J, Deniker P: Drug-induced extrapyramidal syndromes. In Vinken PJ, Bruyn GW (Editors): Handbook of Clinical Neurology; Diseases of the Basal Ganglia. Amsterdam, North Holland Publishing Company, 1968, vol 6, chap 10, pp 248-266
3. Preston J: Central nervous system reactions to small doses of tranquilizers. Am Practitioner 10:627-630, 1959
4. Bourgeois M, Tignol J, Henry P:Syndromesmalinsetmorts subites au cours des traitements par neuroleptiques simples et retard. Ann Med Psychol 129:729-746, 1971
5. Henry P, Barat M, Bourgeois M, et al: Syndrome malin mortel succedant a une injection d'emblee d'oenanthate de fluphenazine. Presse Med 79:1350, 1971
6. Lievre JA, Guillen P, Boccara M: Accident par fluphenazine-retard. Presse Med 79:1757, 1971
7. Allan RN, White HC: Side effects of parenteral long-acting phenothiazines. Br Med J 1:221, 1972
8. Dillon JB: Parenteral long-acting phenothiazines. Br Med J 1:807, 1972
9. Kammerer T, Singer L, Patris M, et al: Syndrome neurolep-tique malin ou surdosage neuroleptique (pipothiazine) (A propos d'une observation). Ann Med Psychol 130:550-554, 1972
10. Aubert C: Les hyperthermics dues aux neuroleptiques: Essai d'interpretation physiopathologique. Encephale 62:126-159, 1973
11. Meltzer HY: Rigidity, hyperpyrexia and coma following fluphenazine enanthate. Psyehopharmacologia 29:337-346, 1973
12. Auzepy P, Poivet D, Nitenberg G: Insufisance respiratoire aigue chez deux schizophrenes: Role eventuel des neuroleptiques retard. Nouv Presse Med 6:1236, 1977
13. Fabre S, Gervais C, Manuel C, et al: Le syndrome des neuroleptiques: A propos de 7 cas. Encephale 3:321-326, 1977
14. Itoh H, Ohtsuka N, Ogita K, et al: Malignant neuroleptic syndrome-its present status in Japan and clinical problems. Folia Psychiatr Neurol Jpn 31:565-576, 1977
15. Dumont A, Minjat M, Blanc JL, et al: Le syndrome malin aux neuroleptiques (a propos de trois observations). Ann Anesthesiol Fr 19:777-782, 1978
16. Geller B, Greydanus DE: Haloperidol-induced comatose state with hyperthermia and rigidity in adolescence: Two case reports with a literature review. J Clin Psychiatry 40:102-103, 1979
17. Grunhaus L, Sancovici S, Rimon R: Neuroleptic malignant syndrome due to depot fluphenazine. J Clin Psychiatry 40:99-100, 1979
18. Powers P, Douglass TS, Waziri R: Hyperpyrexia in catatonic states. Dis Nerv Syst 37:359-361, 1976
19. McAllister RG Jr: Fever, tachycardia, and hypertension with acute catatonic schizophrenia. Arch Intern Med 138:1154-1156, 1978
20. Walker MFC: Simulation of tetanus by trifluoperazine overdosage. Can Med Assoc J 81:109-110, 1959
21. Weinberger DR, Kelly MJ: Catatonia and malignant syndrome: A possible complication of neuroleptic administration. J Nerv Ment Dis 165:263-268, 1977
22. Haberman ML: Malignant hyperthermia: An allergic reaction to thioridazine therapy. Arch Intern Med 138:800-801, 1978
23. Bernstein RA: Malignant neuroleptic syndrome: An atypical case. Psychosomatics 20:840-846, 1979
24. Stauder KH: Die todliche Katatonie. Arch Psychiatr Ner-venkr 102:614-634, 1934
25. Shulack NR; Exhaustion syndrome in excited psychotic patients. Am J Psychiatry 102:466-475, 1946
26. Billig O, Freeman WT: Fatal catatonia. Am J Psychiatry 100:633-638, 1944
27. Laskowska D: Essai d’explication des mecanismes pathophysiologiques menant au developpement du syndrome confuso-catatonique aigu (“catatonie mortelle” de Stauder) au cours de la schizophrenie. Ann Med Psychol 125:549-559, 1967
28. Gjessing R: Disturbances of somatic functions in catatonia with a periodic course, and their compensation. J Ment Sci 84:608-621, 1938
29. Schou M, Amdisen A, Trap-Jensen J: Lithium poisoning. Am J Psychiatry 125:520-527, 1968
30. von Hartitzsch B, Hoenich NA, Leigh RJ, et al: Permanent neurological sequelae despite haemodialysis for lithium intoxication. Br Med J 4:757-759, 1972
31. Juul-Jensen P, Schou M: Permanent brain damage after lithium intoxication. Br Med J 4:673, 1973
32. Cohen WJ, Cohen NH: Lithium carbonate, haloperidol, and irreversible brain damage. JAMA 230:1283-1287, 1974
33. Thornton WE, Thornton BJP: Lithium intoxication: A report of two cases. Can Psychiatr Assoc J 20:281-282, 1975
34. Loudon JB, Waring H: Toxic reactions to lithium and haloperidol. Lancet 2:1088, 1976
35. Ayd FJ Jr: Lithium-haloperidol for mania: Is it safe or hazardous? Int Drug Ther Newsletter 10:29-36, 1975
36. Baastrup PC, Hollnagel P, Sorensen R, et al: Adverse reactions in treatment with lithium carbonate and haloperidol. JAMA 236:2645-2646, 1976
37. Juhl RP, Tsuang MT, Perry PJ: Concomitant administration of haloperidol and lithium carbonate in acute mania. Dis Nerv Syst 38:675-676, 1977
38. Smith DF, Shimizu M, Schou M: Lithium absorption, distribution and clearance and body temperature in rats given lithium plus haloperidol. Pharmacology 15:337-340, 1977
39. Flemenbaum A: Lithium inhibition of norepinephrine and dopamine receptors. Biol Psychiatry 12:563-572, 1977
40. Gallager DW, Pert A, Bunney WE Jr: Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature 273:309-312, 1978
41. Pert A, Rosenblatt JE, Sivit C, et al: Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 201:171-173, 1978
42. Stefanini E, Longoni R, Fadda F, et al: Inhibition by lithium of dopamine-sensitive adenylate-cyclase in the rat brain. J Neurochem 30:257-258, 1978
43. Allikmets LH, Stanley M, Gershon S: The effect of lithium on chronic haloperidol enhanced apomorphine aggression in rats. Life Sci 25:165-170, 1979
44. Mann SC, Boger WP: Psychotropic drugs, summer heat and humidity, and hyperpyrexia: A danger restated. Am J Psychiatry 135:1097-1100, 1978
45. Borbely AA, Loepfe-Hinkkanen M: Phenothiazines. In Lomax P, Schonbaum E (Editors): Body Temperature: Regulation, Drug Effects, and Therapeutic Implications. New York, Marcel Dekker, Inc, 1979, chap 16, pp 403-426
46. Westlake RJ, Rastegar A: Hyperpyrexia from drug combinations. JAMA 225:1250, 1973
47. Greenblatt DJ, Gross PL, Harris J, et al: Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal. J Clin Psychiatry 39:673-675, 1978
48. Scialli JVK, Thornton WE: Toxic reactions from a haloperidol overdose in two children: Thermal and cardiac manifestations. JAMA 239:48-49, 1978
49. Shibolet S, Lancaster MC, Danon Y: Heat stroke: A review. Aviat Space Environ Med 47:280-301, 1976
50. Britt BA, Kalow W: Malignant hyperthermia: A statistical review. Can Anaesth Soc J 17:293-315, 1970
51. Britt BA: Etiology and pathophysiology of malignant hyperthermia. Fed Proc 38:44-48, 1979
52. King JO, Denborough MA, Zapf PW: Inheritance of malignant hyperpyrexia. Lancet 1:365-370, 1972
53. Nicholson MJ: Malignant hyperthermia with subsequent uneventful general anesthesia. Anesth Analg 50:1104-1106, 1971
54. Britt BA: Comment on malignant hyperthermia with subsequent uneventful general anesthesia. Anesth Analg 50:1107-1111, 1971
55. Lomax P: Drugs and body temperature. Int Rev Neurobiol 12:1-43, 1970
56. Reaves TA Jr, Hayward JN: Hypothalamic and extrahypo-thalamic thermoregulatory centers. In Lomax P, Schonbaum E (Editors): Body Temperature: Regulation, Drug Effects, and Therapeutic Implications. New York, Marcel Dekker, Inc, 1979, chap 3, pp 39-70
57. Plum F, Van Uitert R: Nonendocrine diseases and disorders of the hypothalamus. In Reichlin S, Baldessarini RJ, Martin JB (Editors): The Hypothalamus. New York, Raven Press, 1978, pp 415-473
58. Cox B, Kerwin R, Lee TF: Dopamine receptors in the central thermoregulatory pathways of the rat. J Physiol 282:471-483, 1978
59. Lin MT: Effects of brain monoamine depletion on chlorpromazine-induced hypothermia in rabbits. Can J Physiol Pharmacol 57:16-23, 1979
60. Lin MT: Effects of dopaminergic antagonist and agonist on thermoregulation in rabbits. J Physiol 293:217-228, 1979
61. Gilat G, Shibolet S, Sohar E: The mechanism of heatstroke. J Trop Med Hyg 66:204-212, 1963
62. Hill AV: The priority of the heat production in a muscle twitch. Proc R Soc Lond (Biol) 148:397-402, 1958
63. Bligh J, Cottle WH, Maskrey M: Influence of ambient temperature on the thermoregulatory responses to 5-hydroxytryptamine, noradrenalin and acetylcholine injected into the lateral cerebral ventricles of sheep, goats and rabbits. J Physiol 212:377-392, 1971
64. Feldberg W, Myers RD: Effects on temperature of amines injected into the cerebral ventricles. A new concept of temperature regulation. J Physiol 173:226-237, 1964
65. Cox B: Dopamine. In Lomax P, Schonbaum E (Editors): Body Temperature: Regulation, Drug Effects, and Therapeutic Implications. New York, Marcel Dekker, Inc, 1979, chap 9, pp 234-255
66. Maickel RP: Interaction of drugs with autonomic nervous function and thermoregulation. Fed Proc 29:1973-1979, 1970
67. Yehuda S, Wurtman RJ: The effects of D-amphetamine and related drugs on colonic temperatures of rats kept at various ambient temperatures. Life Sci 11:851-859, 1972
68. Kruk ZL: The effect of drugs acting on dopamine receptors on the body temperature of the rat. Life Sci 11:845-850, 1972
69. Kennedy MS, Burks TF: Dopamine receptors in the central thermoregulatory mechanism of the cat. Neuropharmacology 13:119-128, 1974
70. Tangri KK, Bhargava AK, Bhargava KP: Interrelation between monoaminergic and cholinergic mechanisms in the hypothalamic thermoregulatory centre of rabbits. Neuropharmacology 13:333-346, 1974
71. Yehuda S, Wurtman RJ: Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine. Nature 240:477-478, 1972
72. Davies JA, Redfern PH: A note on the effect of amantadine on body temperature in mice. J Pharm Pharmacol 25:705-707, 1973
73. Fuxe K, Sjoqvist F: Hypothermic effect of apomorphine in the mouse. J Pharm Pharmacol 24:702-705, 1972
74. Quock RM, Carino MA, Horita A: Thermotropic activity of apomorphine in the rabbit: A central site of action. Life Sci 16:525-532, 1975
75. Reid JL: Dopamine supersensitivity in the hypothalamus? Adv Neurol 9:73-80, 1975
76. Mackay AVP, Davies P, Dewar AJ, et al: Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. J Neurochem 30:827-839, 1978
77. Mackay AVP, Yates CM, Wright A, et al: Regional distribution of monoamines and their metabolites in the human brain. J Neurochem 30:841-848, 1978
78. Palkovits M, Brownstein M, Saavedra JM, et al: Norepinephrine and dopamine content of hypothalamic nuclei of the rat. Brain Res 77:137-149, 1974
79. Kebabian JW, Calne DB: Multiple receptors for dopamine. Nature 277:93-96, 1979
80. Cox B, Lee TF: Location of receptors mediating hypothermia after injection of dopamine agonists in rats. Br J Pharmacol 59:467P-468P, 1977
81. Yehuda S, Wurtman RJ: Dopaminergic neurons in the nigro-striatal and mesolimbic pathways: Mediation of specific effects of D-amphetamine. Eur J Pharmacol 30:154-158, 1975
82. Hornykiewicz O: Dopamine and extrapyramidal motor function and dysfunction. Res Publ Assoc Res Nerv Ment Dis 50:390-412, 1972